Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial (Q44442912)
Jump to navigation
Jump to search
scientific article published on 8 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial |
scientific article published on 8 October 2012 |
Statements
1 reference
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial (English)
1 reference
1 reference
Dirk Schadendorf
1 reference
Paolo A Ascierto
1 reference
Axel Hauschild
1 reference
Lisa Zimmer
1 reference
Alain Algazi
1 reference
Vicki Goodman
1 reference
Laurent Mortier
1 reference
Uwe Trefzer
1 reference
Michael A Davies
1 reference
Paul B Chapman
1 reference
Igor Puzanov
1 reference
Hussein Tawbi
1 reference
Tabea Wilhelm
1 reference
Julie Switzky
1 reference
Suzanne Swann
1 reference
Anne-Marie Martin
1 reference
Mary Guckert
1 reference
Michael Streit
1 reference
John M Kirkwood
1 reference
8 October 2012
1 reference
1 reference
Identifiers
1 reference